Found 6 matching trials
A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
PHASE1This is a Phase 1b open-label, single arm, multicenter, study of ALRN-6924 ...
Location
Oncology and Hematology Associates of West Broward
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
PHASE1This is a Phase 1b, multicenter, 2-part study of ALRN-6924 for the preventi...
Location
Arizona Cancer Center
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
PHASE1This phase Ib trial studies the side effects and best dose of ALRN-6924 whe...
Location
M D Anderson Cancer Center
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas
PHASE1This study evaluates the anti-tumor effects of ALRN-6924 in patients with a...
Location
Multiple Locations
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
PHASE1Phase 1/1b, open label, multi-center dose escalation and dose expansion stu...
Location
Multiple Locations
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
PHASE1This research study is studying a novel drug called ALRN-6924 as a possible...
Location
UCSF Benioff Children's Hospital